Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

EGYPT: Egypt Launches World's Largest Hepatitis C Patient Registry


Ahram Online (10.22.12)

With the approval of the Ministry of Health, Egypt’s National Committee for the Control of Viral Hepatitis launched its first national hepatitis C virus (HCV) patient registry on October 18. According to Dr. Wafaa El-Akel, executive manager of the HCV patient registry, Egypt has the highest percentage of HCV infections worldwide. She stated that about 10 percent of Egyptians have HCV infection. Dr. El-Akel noted that the network is important in that it helps assess the extent of issues associated with the virus, helps maintain quality patient care, and prevents infection by analyzing new data and determining the most common means of infection. Dr. Wahid Doss, dean of the National Liver Institute, noted that the registry ushers in a new era in controlling the disease in Egypt by centralizing records for patients receiving treatment at liver centers nationwide. So far, it contains records of more than 32,000 patients. He anticipates the project will transform HCV treatment by effectively managing resources to get the highest cure rates, closely monitoring patient progress, and tracking the number of injections dispensed to determine patient compliance. Dr. Doss expressed gratitude for Hoffmann La Roche’s support and efforts toward treating HCV in Egypt and the Academy of Scientific Research and Technology. The National Committee launched the National Project for hepatitis C treatment in 2006, and more than 240,000 patients have been treated at the state’s expense at 23 liver centers nationwide. The Ministry of Health has spent approximately 2 billion Egyptian pounds ($300 million) to support the project and has worked with manufacturing companies to provide globally-approved treatments at the lowest cost worldwide.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in October 23, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.